Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection

NCT03312023 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B

Interventions

DRUG: Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni]
DRUG: Sofosbuvir 400 MG [Sovaldi]
DRUG: Ledipasvir 90 MG

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]